Edwards, J. (2021) Matched hormone naïve and castrate resistant prostate cancer specimens. [Data Collection]
Related Enlighten Publications
- Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer
- Determining the prognostic significance of IKKα in prostate cancer
- Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence
- Androgen receptor phosphorylation at serine 308 and serine 791 predicts enhanced survival in castrate resistant prostate cancer patients
- NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression
Collection description
This database was established to allow investigation of biomarkers associated with the transition from hormone naïve to castrate resistant prostate cancer.
Safehaven number: GSH/18/ON/009
109 patients with hormone-naïve and castrate resistant tumour pairs were included within this database (diagnosed between 1984 and 2000 with locally advanced or metastatic CaP from Greater Glasgow and Clyde Health Board).
Patients were selected based on their response to hormone treatment (sub-capsular bilateral orchi- dectomy or LHRH agonists combined with anti-androgens) and their relapse (two rises in PSA > 10%).
Hormone Naïve tissue was obtained via trans-rectal ultrasound guided biopsies and Castrate resistant tissue was obtained by transurethral resection of the prostate as a result of relieving bladder outflow obstruction.
Clinical data included age, Gleason score, serum PSA levels at diagnosis, biochemical recurrence, serum PSA at biochemical recurrence and presence of metastases.
Study end points were biochemical relapse, survival from biochemical relapse and disease-specific survival.
Ethical approval was acquired from Multicentre Research Ethics Committee for Scotland (MREC/01/0/36) and Local Research and Ethics Committees.
| Funding: |
|
|---|---|
| College / School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences > Experimental Therapeutics |
| Date Deposited: | 01 Nov 2021 16:03 |
| URI: | https://researchdata.gla.ac.uk/id/eprint/1208 |
Repository Staff Only: Update this record